141 related articles for article (PubMed ID: 36503870)
1. IL-7 and IL-7R in health and disease: An update through COVID times.
Fernandes MB; Barata JT
Adv Biol Regul; 2023 Jan; 87():100940. PubMed ID: 36503870
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
3. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
[TBL] [Abstract][Full Text] [Related]
4. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
5. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
[TBL] [Abstract][Full Text] [Related]
6. Flip the coin: IL-7 and IL-7R in health and disease.
Barata JT; Durum SK; Seddon B
Nat Immunol; 2019 Dec; 20(12):1584-1593. PubMed ID: 31745336
[TBL] [Abstract][Full Text] [Related]
7. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract][Full Text] [Related]
8. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
Roifman CM; Zhang J; Chitayat D; Sharfe N
Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
[TBL] [Abstract][Full Text] [Related]
9. [Mutation of IL-7R in Adult Patients with T-cell Acute Lymphoblastic Leukemia and Its Clinical Significance].
Xiao LC; Li M; Ge Z; Gu Y; Zhou XL; Guo X; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1014-8. PubMed ID: 27531766
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway.
Watanabe M; Yamazaki M; Okamoto R; Ohoka S; Araki A; Nakamura T; Kanai T
Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):119-23. PubMed ID: 14561163
[TBL] [Abstract][Full Text] [Related]
11. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
[TBL] [Abstract][Full Text] [Related]
12. [Mutation and Clinical Feature of IL-7R in Adult Patients with Acute Lymphoblastic Leukemia].
Fu GM; Chen DD; Wu C; Wang M; Pan ZX; Peng XY; Sun H; Sun L; Liu YF; Jiang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1416-1423. PubMed ID: 31607292
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-7 in T-cell development from hematopoietic stem cells.
Akashi K; Kondo M; Weissman IL
Immunol Rev; 1998 Oct; 165():13-28. PubMed ID: 9850848
[TBL] [Abstract][Full Text] [Related]
14. IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway.
Qu H; Zou Z; Pan Z; Zhang T; Deng N; Chen G; Wang Z
Int Immunopharmacol; 2016 Nov; 40():203-210. PubMed ID: 27611862
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of IL-7/IL-7R signalling on the osteoimmunological system: a potential therapeutic target for rheumatoid arthritis.
Xu H; Cai L; Li Z; Zhang L; Wang G; Xie R; Jiang Y; Yuan Y; Nie H
Immunology; 2021 Sep; 164(1):161-172. PubMed ID: 33934341
[TBL] [Abstract][Full Text] [Related]
16. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity.
Ryan DH; Nuccie BL; Ritterman I; Liesveld JL; Abboud CN; Insel RA
Blood; 1997 Feb; 89(3):929-40. PubMed ID: 9028324
[TBL] [Abstract][Full Text] [Related]
18. A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia.
Akkapeddi P; Fragoso R; Hixon JA; Ramalho AS; Oliveira ML; Carvalho T; Gloger A; Matasci M; Corzana F; Durum SK; Neri D; Bernardes GJL; Barata JT
Leukemia; 2019 Sep; 33(9):2155-2168. PubMed ID: 30850736
[TBL] [Abstract][Full Text] [Related]
19. Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.
Rodrigues GOL; Cramer SD; Winer HY; Hixon JA; Li W; Yunes JA; Durum SK
Adv Biol Regul; 2021 May; 80():100788. PubMed ID: 33578108
[TBL] [Abstract][Full Text] [Related]
20. The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
Wang C; Kong L; Kim S; Lee S; Oh S; Jo S; Jang I; Kim TD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
